This company listing is no longer active
HAEMATO Past Earnings Performance
Past criteria checks 4/6
HAEMATO has been growing earnings at an average annual rate of 15.3%, while the Healthcare industry saw earnings declining at 1.6% annually. Revenues have been growing at an average rate of 0.8% per year. HAEMATO's return on equity is 6.4%, and it has net margins of 3.7%.
Key information
15.3%
Earnings growth rate
-11.1%
EPS growth rate
Healthcare Industry Growth | 15.7% |
Revenue growth rate | 0.8% |
Return on equity | 6.4% |
Net Margin | 3.7% |
Last Earnings Update | 30 Jun 2023 |
Recent past performance updates
Recent updates
What Is HAEMATO AG's (ETR:HAEK) Share Price Doing?
Feb 22Potential Upside For HAEMATO AG (ETR:HAEK) Not Without Risk
Jan 04The Returns At HAEMATO (ETR:HAEK) Aren't Growing
Sep 12HAEMATO's (ETR:HAEK) Dividend Will Be Increased To €1.20
May 20We Like These Underlying Return On Capital Trends At HAEMATO (ETR:HAEK)
May 12HAEMATO's (ETR:HAEK) Returns On Capital Are Heading Higher
Dec 08The Strong Earnings Posted By HAEMATO (ETR:HAEK) Are A Good Indication Of The Strength Of The Business
May 24HAEMATO (ETR:HAEK) Hasn't Managed To Accelerate Its Returns
Nov 17HAEMATO (ETR:HAEK) Will Be Hoping To Turn Its Returns On Capital Around
May 30We're Not Very Worried About HAEMATO's (ETR:HAEK) Cash Burn Rate
Mar 08What Do The Returns At HAEMATO (ETR:HAEK) Mean Going Forward?
Feb 15Estimating The Fair Value Of HAEMATO AG (ETR:HAEK)
Jan 25Is Now An Opportune Moment To Examine HAEMATO AG (ETR:HAEK)?
Jan 04Reflecting on HAEMATO's (ETR:HAEK) Share Price Returns Over The Last Three Years
Dec 14Revenue & Expenses Breakdown
How HAEMATO makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 23 | 261 | 10 | 4 | 0 |
31 Mar 23 | 254 | 9 | 5 | 0 |
31 Dec 22 | 248 | 8 | 5 | 0 |
30 Sep 22 | 251 | 4 | 6 | 0 |
30 Jun 22 | 254 | 0 | 7 | 0 |
31 Mar 22 | 270 | 3 | 7 | 0 |
31 Dec 21 | 285 | 7 | 8 | 0 |
30 Sep 21 | 280 | 6 | 7 | 0 |
30 Jun 21 | 274 | 5 | 7 | 0 |
31 Mar 21 | 256 | 0 | 7 | 0 |
31 Dec 20 | 238 | -5 | 7 | 0 |
30 Sep 20 | 229 | -3 | 7 | 0 |
30 Jun 20 | 220 | -2 | 7 | 0 |
31 Mar 20 | 209 | -2 | 7 | 0 |
31 Dec 19 | 198 | -1 | 6 | 0 |
30 Sep 19 | 211 | -1 | 6 | 0 |
30 Jun 19 | 224 | -1 | 6 | 0 |
31 Mar 19 | 249 | 3 | 6 | 0 |
31 Dec 18 | 274 | 6 | 6 | 0 |
30 Sep 18 | 284 | 8 | 6 | 0 |
30 Jun 18 | 294 | 10 | 6 | 0 |
31 Mar 18 | 292 | 8 | 6 | 0 |
31 Dec 17 | 289 | 7 | 6 | 0 |
30 Sep 17 | 281 | 8 | 6 | 0 |
30 Jun 17 | 272 | 9 | 5 | 0 |
31 Mar 17 | 274 | 10 | 5 | 0 |
31 Dec 16 | 276 | 11 | 5 | 0 |
30 Sep 16 | 273 | 9 | 5 | 0 |
30 Jun 16 | 271 | 7 | 6 | 0 |
31 Mar 16 | 250 | 6 | 6 | 0 |
31 Dec 15 | 230 | 6 | 5 | 0 |
30 Sep 15 | 210 | 5 | 7 | 0 |
30 Jun 15 | 190 | 5 | 5 | 0 |
31 Mar 15 | 196 | 6 | 5 | 0 |
31 Dec 14 | 203 | 7 | 5 | 0 |
30 Sep 14 | 214 | 9 | -1 | 0 |
30 Jun 14 | 224 | 10 | 4 | 0 |
31 Mar 14 | 199 | 9 | 4 | 0 |
31 Dec 13 | 174 | 8 | 0 | 0 |
30 Sep 13 | 126 | 7 | 3 | 0 |
30 Jun 13 | 79 | 7 | 2 | 0 |
Quality Earnings: HAEK has a large one-off gain of €2.9M impacting its last 12 months of financial results to 30th June, 2023.
Growing Profit Margin: HAEK's current net profit margins (3.7%) are higher than last year (0.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: HAEK's earnings have grown by 15.3% per year over the past 5 years.
Accelerating Growth: HAEK's earnings growth over the past year (2578%) exceeds its 5-year average (15.3% per year).
Earnings vs Industry: HAEK earnings growth over the past year (2578%) exceeded the Healthcare industry -4.2%.
Return on Equity
High ROE: HAEK's Return on Equity (6.4%) is considered low.